ClinicalTrials.gg
CompletedNCT02996279S100A12Updated Dec 19, 2016

Chorioamnionitis and Proinflammatory S100A12

An observational study in Chorioamnionitis Affecting Fetus or Newborn, sponsored by Catholic University of the Sacred Heart. Completed. Per ClinicalTrials.gov, last updated 2016-12-19.

Sponsored by Catholic University of the Sacred Heart · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
69
Sex
All
01

Study summary

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS) and increased levels of proinflammatory molecules.

Read the detailed description

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS). The aim of this pilot study was to evaluate S100A12, a marker of innate immune activation, in mothers with or without HCA and in their infants.

Concentrations of S100A12, Interleukin 6 (IL-6) and C-reactive protein (CRP) were evaluated in maternal, cord, and neonatal blood of very preterm infants. Histologic examinations of placentae and umbilical cords were performed.

02

Conditions studied

  • Chorioamnionitis Affecting Fetus or Newborn

Browse trials for

Keywords

  • Neonate
  • Chorioamnionitis
  • S100A12
03

In context

Chorioamnionitis

39 studies on the registry are indexed under Chorioamnionitis; 9 are open to participants now.

This study's enrollment of 69 is below the median of 125 across 14 observational studies indexed under Chorioamnionitis.

Browse Chorioamnionitis studies →

Lead sponsor

Catholic University of the Sacred Heart is the lead sponsor of 237 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Very Premature Mother-Neonate Pairs

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Preterm Birth

Exclusion criteria

Exclusion Criteria:

Congenital Abnormalities

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
69 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • group 1

    maternal chorioamnionitis

  • group 2

    no maternal chorioamnionitis

06

What researchers measure

Primary outcomes

  1. S100A12 in Presence of Maternal Chorioamnionitis

    Levels of S100A12 in Maternal, Cord and Neonatal Blood in the Presence or Absence of HCA

    Time frame: 1 Year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2012, a primary completion of Feb 2013 and a completion of Mar 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 25, 2016
First posted
Dec 19, 2016
Start
Feb 2012
Primary completionActual
Feb 2013
CompletionActual
Mar 2013
Last update
Dec 19, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02996279
Responsible party
MARIA PIA DE CAROLIS (MD, Catholic University of the Sacred Heart) — Principal investigator
First posted
Dec 19, 2016
Start date
Feb 2012
Primary completion
Feb 2013
Completion
Mar 2013
Last update
Dec 19, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion